1.

Record Nr.

UNINA990009266760403321

Titolo

Das Recht der Gegenwart : ein Führer durch das in Deutschland geltende Recht / hrsg. von Franz Schlegelberger unter Mitw. von Hartwig Schlegelberger

Pubbl/distr/stampa

Berlin : Vahlen, 1956

Edizione

[2. Ausg., Stand vom 31. Dez. 1955]

Descrizione fisica

IX, 497 p. ; in 8°

Disciplina

340.43

Locazione

FGBC

Collocazione

XVIII 37

XVIII 117

Lingua di pubblicazione

Tedesco

Formato

Materiale a stampa

Livello bibliografico

Monografia



2.

Record Nr.

UNINA990001707450403321

Autore

Screm, Egidio

Titolo

Impressioni da viaggio di studio in alcuni parchi nazionali degli Stati Uniti del Canada / Egidio Screm

Pubbl/distr/stampa

Roma, : Ministero dell' Agricoltura e delle Foreste, 1971

Descrizione fisica

101 p. ; 24 cm

Collana

Collana verde ; 26

Disciplina

639.95

Locazione

FAGBC

Collocazione

60 634.9 B 22

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia

3.

Record Nr.

UNINA9910437830803321

Titolo

Cancer immunotherapy : paradigms, practice and promise / / Tyler Curiel, editor

Pubbl/distr/stampa

New York, : Springer, 2013

ISBN

1-283-84897-X

1-4614-4732-1

Descrizione fisica

1 online resource (485 p.)

Altri autori (Persone)

CurielTyler

Disciplina

616.99

616.994061

Soggetti

Cancer - Immunological aspects

Immunotherapy

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.



Nota di contenuto

pt. I. Overview -- pt. II. Passive strategies to boost antitumor immunity -- pt. III. Active strategies to boost antitumor immunity -- pt. IV. Additional strategies and considerations.

Sommario/riassunto

This volume is a comprehensive discussion of the major factors affecting tumor immunology and a discussion of all major anti-cancer immunotherapeutic agents approved by the Food and Drug Administration of the United States and by European agencies. Many promising but unapproved agents in clinical trials are also discussed, as are key pre-clinical developments. The major challenges and intellectual issues facing investigators developing novel immunotherapeutics are discussed in detail as are conceptual developments influencing current and future treatment strategies. Each chapter begins by defining all relevant key terms and concepts and provides pertinent background information so that the text will be accessible to newcomers to the field as well as to the expert. This text book should provide an excellent reference resource for investigators in tumor immunology, life sciences students, drug developers designing novel anti-cancer immunotherapeutics, and to other individuals with some scientific training wishing to gain a better understanding of the field of tumor immunotherapy. Although the field is evolving rapidly, we have taken pains to ensure that information was as up to date as possible as the text went to press.